Research advances in thermal ablation for lung cancer
- VernacularTitle:热消融治疗肺癌的研究进展
- Author:
Ziqiang HONG
1
;
Dacheng JIN
2
;
Xiangdou BAI
1
;
Baiqiang CUI
1
;
Yunjiu GOU
2
Author Information
1. 1. First Clinical Medical School, Gansu University of Chinese Medicine, Lanzhou, 730000, P. R. China 2. Department of Thoracic Surgery, Gansu Provincial Hospital, Lanzhou, 730000, P. R. China
2. Department of Thoracic Surgery, Gansu Provincial Hospital, Lanzhou, 730000, P. R. China
- Publication Type:Journal Article
- Keywords:
Lung cancer;
metastatic cancer;
thermal ablation;
radiofrequency ablation;
microwave ablation;
argon-helium cryoablation;
review
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2024;31(01):166-172
- CountryChina
- Language:Chinese
-
Abstract:
Although surgical resection remains to be the best treatment strategy for stageⅠnon-small cell lung cancer (NSCLC), percutaneous thermal ablation offers an important option for patients who are unable to undergo surgical resection. Currently, there are three main thermal ablation methods used in the treatment of lung cancer, including radiofrequency ablation (RFA), microwave ablation (MWA) and argon-helium cryoablation (AHC). With the improvement of technique and the accumulation of experience in the treatment of lung cancer, some limitations are disclosed in the initial application of RFA, such as heat sink effect, skin burns and rapid carbonization. These shortcomings have been overcome in the development of MWA and AHC. The feasibility and safety of thermal ablation for the treatment of lung cancer has been demonstrated and its efficacy has been significantly improved (especially for the tumour diameter≤3 cm). This article will focus on the application and recent research developments of these ablation techniques in the treatment of lung cancer.
